GoldBamboo.com - Knowledge is strong medicine
  

HEARING Trial: Hearing Aid Effectiveness After Aural Rehabilitation - Article


  Not Signed In - Sign In / Register







[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Deafness & Hearing Loss




Clinical Trial: HEARING Trial: Hearing Aid Effectiveness After Aural Rehabilitation

This study is not yet open for patient recruitment.
Verified by Department of Veterans Affairs November 2005

Sponsors and Collaborators: Department of Veterans Affairs
University of Washington
Information provided by: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00260663

Purpose

The number of hearing aids dispensed by the Department of Veterans Affairs (VA) has nearly quadrupled from 75,000 in 1996 to over 283,000 in 2003. However, the number of audiologists serving this population has less than doubled (72% increase) in the same period. This imbalance has resulted in burgeoning waiting times for audiology appointments, negatively impacting the quality of life of thousands of veterans while they wait for hearing aids. Reduction in waiting times through more efficient use of limited resources while maintaining high quality care is of great interest to VA leadership.
Condition Intervention
Hearing Loss
 Procedure: Group hearing aid fittings
 Procedure: Group hearing aid follow-up

MedlinePlus related topics:  Hearing Disorders and Deafness

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Factorial Assignment, Efficacy Study

Official Title: Hearing Aid Effectiveness After Aural Rehabilitation (HEAR) Trial

Further study details as provided by Department of Veterans Affairs:
Primary Outcomes: Hearing-related quality of life; hearing aid adherence
Secondary Outcomes: Satisfaction; costs; utilization
Expected Total Enrollment:  660

Study start: April 2006;  Expected completion: January 2009
Last follow-up: June 2008;  Data entry closure: September 2008

Background:

The number of hearing aids dispensed by the VA has nearly quadrupled from 75,000 in 1996 to over 283,000 in 2003. However, the number of audiologists serving this population has less than doubled (72% increase) in the same period. This imbalance has resulted in burgeoning waiting times for audiology appointments, negatively impacting the quality of life of thousands of veterans while they wait for hearing aids. Reduction in waiting times through more efficient use of limited resources while maintaining high quality care is of great interest to VA leadership.

Objectives:

The orientation portion of the hearing aid fitting appointment and the hearing aid follow-up visit 4 weeks later impart standard information relevant to all new hearing aid patients, and may be highly conducive to group format. Our specific aims are to compare group visits and the current standard of individual aural rehabilitation appointments to determine if:

  1. group visits are at least as effective (‘non-inferior’) as individual visits for each audiology appointment, and
  2. the use of group visits leads to lower costs for the VA.

Methods:

The researchers propose a non-inferiority, randomized clinical trial to compare the effectiveness of group versus individual audiology appointments. They will compare group versus individual visits for two types of audiology appointments: hearing aid fitting (orientation only) and hearing aid follow-up. The researchers hypothesize that:

  1. group visits are at least as effective as individual visits, as measured by hearing-related quality of life and hearing aid adherence; and
  2. group visits lead to cost savings, not just in the immediate treatment period, but throughout a 6-month aural rehabilitation period.

Setting and Population:

The researchers propose to enroll 660 new hearing aid patients from the audiology clinics at the Seattle and American Lake Divisions of VA Puget Sound Health Care System.

Randomized Interventions:

Patients will be randomized to group versus individual orientation (intervention #1) and group versus individual follow-up (intervention #2) visits.

Findings:

This study has not yet started.

Status:

This study has not yet started.

Impact:

The primary effectiveness outcome will be hearing-related quality of life 6 months after the hearing aid fitting. Secondary effectiveness outcomes will include hearing aid adherence and satisfaction with hearing amplification. Cost and utilization outcomes will include audiology labor for the initial visits and subsequent unplanned visits, the cost of hearing aids, and the number of hearing aid repairs. The researchers selected a time frame of 6 months because pilot data show that 75% of unplanned visits occur in the first 6 months.

Analysis:

An intention-to-treat analysis will be used to minimize bias due to subject self-selection. The researchers have chosen a sample size adequate to detect non-inferiority of hearing-related quality of life in patients undergoing group rehabilitation in either intervention. Analyses for each intervention will be stratified by degree of hearing loss, binaural versus monaural hearing aid use, and group versus individual appointment of the other intervention. Cost-effectiveness analyses will be pursued if greater effectiveness and higher costs are both documented, in which case pilot calculations of the unit cost to obtain an additional successfully treated patient (those with a clinically important improvement of 6 points on the Inner EAR scale) will be made.

Benefit to VA:

This proposal directly addresses three of the VA’s designated research areas: sensory disorders, aging, and health services. In addition, this application is directly responsive to a Health Services Research and Development Service (HSR&D) solicitation on sensory disorders and loss. This project has the potential to help VA leadership identify more efficient treatment that maintains high quality care for one of the most common disabilities in veterans, and to provide insight into the value of group visits as a model of care.

Eligibility

Genders Eligible for Study:  Both
Criteria

Inclusion Criteria:

  • New hearing aid users at VA Puget Sound

Exclusion Criteria:

  • Prior hearing aid users;
  • Inability to participate in group rehabilitation sessions or to complete follow-up

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00260663

Bevan Yueh, MD, MPH      (206) 764-2424    bevan.yueh@med.va.gov

Washington
      VA Puget Sound Health Care System, Seattle,  Washington,  98109,  United States
Jane Summerfield, MA  206-764-2848    jane.summerfield@med.va.gov 
Jean H Sullivan, BA  (206) 768-5337    jean.sullivan@med.va.gov 
Bevan Yueh, MD, MPH,  Principal Investigator

Study chairs or principal investigators

Bevan Yueh, MD, MPH,  Principal Investigator,  VA Puget Sound Health Care System   

More Information

Study ID Numbers:  SLI 04-265
Last Updated:  January 3, 2006
Record first received:  November 29, 2005
ClinicalTrials.gov Identifier:  NCT00260663
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2006-01-10

Resources



Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Deafness & Hearing Loss.

December 4, 2008



Page Updated: September 6, 2005
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC - All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.